Therapy monitoring with FDG-PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.

被引：0
|
作者：
Dimitrakopoulou-Strauss, A
Rudi, J
Strauss, LG
机构：
[1] Univ Heidelberg, Med Clin, Heidelberg, Germany
[2] German Canc Res Ctr, D-6900 Heidelberg, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
446
引用
收藏
页码：113P / 113P
页数：1
相关论文
共 50 条
  • [41] Unplanned delays among patients receiving FOLFOX chemotherapy for colorectal cancer.
    Kogan, Lawrence
    Jankowski, Mika
    O'Bryant, Cindy L.
    Davis, Sarah Lindsey
    Brooks, Gabriel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] FDG-PET improves the staging and selection of patients with recurrent colorectal cancer
    Max Lonneux
    Abdel-Malek Reffad
    Roger Detry
    Alex Kartheuser
    Jean-François Gigot
    Stanislas Pauwels
    European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : 915 - 921
  • [43] Outcomes for matched patients with metastatic colitis-associated cancers versus sporadic colorectal cancer receiving chemotherapy.
    Yaeger, Rona
    Hersch, Jonathan
    Bates, David
    Paroder, Viktoriya
    Chou, Joanne F.
    Tang, Laura H.
    Gollub, Marc Jeffrey
    Capanu, Marinela
    Kelsen, David Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] The impact of cumulative toxicity on physical quality of life in patients with metastatic colorectal cancer receiving first line chemotherapy.
    Schuurhuizen, Claudia
    Konings, Inge
    Braamse, Annemarie
    Buffart, Laurien
    Bloemendal, Haiko
    Dekker, Joost
    Verheul, Henk M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] FDG-PET improves the staging and selection of patients with recurrent colorectal cancer
    Lonneux, M
    Reffad, AM
    Detry, R
    Kartheuser, A
    Gigot, JF
    Pauwels, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (07) : 915 - 921
  • [46] FDG-PET imaging predicts response to chemotherapy in lung cancer patients
    不详
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 783 - 783
  • [47] FDG-PET improves the management of patients with suspected recurrence of colorectal cancer
    Simó, M
    Lomeña, F
    Setoain, J
    Pérez, G
    Castellucci, P
    Costansa, JM
    Setoain-Quinquer, J
    Doménech-Torné, F
    Carrió, I
    NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (10) : 975 - 982
  • [48] Early therapy monitoring with FDG-PET in patients with malignant lymphoma.
    Torizuka, T
    Nodezawa, S
    Kobayashi, M
    Kanno, T
    Futatsubashi, N
    Yoshikawa, E
    Okada, N
    Ouchi, Y
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 118P - 118P
  • [49] Functioning of people with colorectal cancer during chemotherapy. Demographic and clinical determinants of quality of life of patients with colorectal cancer receiving chemotherapy. Pilot study
    Gozdziewicz, B.
    Strugala, M.
    Talarska, D.
    Stanislawska, J.
    Baczyk, G.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (03)
  • [50] Prediction of therapy outcome with FDG PET in metastatic colorectal cancer.
    Dimitrakopoulou-Strauss, A
    Strauss, LG
    Rudi, J
    Burger, C
    Haberkorn, U
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 25P - 25P
12345